sofosbuvir has been researched along with Disease Models, Animal in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Chu, JN; Collins, J; Eweje, F; Faiz, MT; Gwynne, D; Hayward, A; Hess, K; Hua, T; Ishida, K; Katz, S; Koeppen, R; Langer, R; Lopes, A; McManus, R; Miller, JB; Salama, JAF; Slocum, AH; Soares, V; Steiger, C; Sulkowski, MS; Tamang, SM; Thomas, DL; Traverso, G; Verma, M | 1 |
Barbosa-Lima, G; Bastos, MM; Boechat, N; Bozza, FA; Bozza, PT; Costa, VV; de Freitas, CS; Delvecchio, R; Ferreira, AC; Higa, LM; Hoelz, LVB; James Westgarth, H; Leme, RPP; Lima, CX; Lopes, CEM; Mattos, M; Monteiro, FL; Queiroz-Junior, CM; Reis, PA; Rocha, N; Rodrigues, GOL; Sacramento, CQ; Souza, TML; Tanuri, A; Teixeira, MM; Vieira, YR | 1 |
2 other study(ies) available for sofosbuvir and Disease Models, Animal
Article | Year |
---|---|
Development of a long-acting direct-acting antiviral system for hepatitis C virus treatment in swine.
Topics: Animals; Antiviral Agents; Benzimidazoles; Carbamates; Cost-Benefit Analysis; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Fluorenes; Hepacivirus; Hepatitis C, Chronic; Imidazoles; Liver Cirrhosis; Models, Animal; Pyrrolidines; Ribavirin; Sofosbuvir; Swine; Valine | 2020 |
Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo.
Topics: Animals; Antiviral Agents; Chlorocebus aethiops; Disease Models, Animal; Drug Resistance, Viral; Hep G2 Cells; Humans; Mice; Mice, Knockout; RNA, Viral; Sofosbuvir; Vero Cells; Yellow Fever; Yellow fever virus | 2019 |